Respiratory Tract Infection Market (Drugs - Antibiotics, Non-steroidal Anti-inflammatory Drugs, Nasal Decongestants, Cough Suppressants, and Other Drugs; Disease Indication - Upper Respiratory Tract Infection, and Lower Respiratory Tract Infection; Distribution Channels - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025. The global respiratory tract infection market is projected to grow at a CAGR of 6.4% over the forecast period of 2019-2025.
Pune, India -- (SBWIRE) -- 05/11/2020 -- Infinium Global Research has recently published a global report on "Respiratory Tract Infection Market (Drugs - Antibiotics, Non-steroidal Anti-inflammatory Drugs, Nasal Decongestants, Cough Suppressants, and Other Drugs; Disease Indication - Upper Respiratory Tract Infection, and Lower Respiratory Tract Infection; Distribution Channels - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025."
To Know More Request Sample of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/14888
Increase in the Elderly Population
The increasing number of respiratory complications in children and the geriatric population is the major factor driving the growth of the respiratory tract infection market. According to UNICEF, in 2016, nearly 8.9 million Americans were diagnosed with chronic bronchitis and nearly 75 percent of cases involved people over the age of 45. Furthermore, nearly 3.5 million people were diagnosed with emphysema in the same year.
However, increasing the incidence of antibiotic resistance and adverse events relating to the consumption of NSAIDs will hamper the growth of the respiratory infection market during the forecast period. Moreover, rapid industrialization in the developing countries leading to increased air and water pollution is expected to drive the respiratory tract infection treatment market in the next few years.
"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Respiratory Tract Infection Market is Included in the Report for Free."
North America is Anticipated to Hold a Premium Share
North America holds the largest market share and is expected to dominate the respiratory tract infection market over the forecast period. This is primarily due to an increase in the geriatric population in the region. Furthermore, the rise in multi-drug resistance bacterial infection among children and immune-compromised adults also fuels the growth of the market in the North American region. The Asia Pacific is likely to grow at a beneficial rate due to the increase in patient awareness, better health care infrastructure, and facilities, high disposable income, occurrence of an unhealthy lifestyle, etc.
Get this Section as a Free Customization in the Report Along With 30% Discount on the Study. https://www.infiniumglobalresearch.com/reports/customization/14888
"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Respiratory Tract Infection Amidst COVID-19"
Respiratory Tract Infection Market Coverage
Chapter - 1 Preface
=> Report Description
=> Research Methods
=> Research Approaches
Chapter - 2 Executive Summary
=> Respiratory Tract Infection Market Highlights
=> Respiratory Tract Infection Market Projection
=> Respiratory Tract Infection Market Regional Highlights
Chapter - 3 Global Respiratory Tract Infection Market Overview
=> Market Dynamics
=> Porter's Five Forces Analysis
=> IGR-Growth Matrix Analysis
=> Value Chain Analysis of Respiratory Tract Infection Market
Chapter - 4 Respiratory Tract Infection Market Macro Indicator Analysis
Chapter - 5 Global Respiratory Tract Infection Market by Drugs
=> Non-steroidal Anti-inflammatory Drugs
=> Nasal Decongestants
=> Cough Suppressants
=> Other Drugs
Chapter - 6 Global Respiratory Tract Infection Market by Disease Indication
=> Upper Respiratory Tract Infection
=> Lower Respiratory Tract Infection
Chapter - 7 Global Respiratory Tract Infection Market by Distribution Channels
=> Hospital Pharmacies
=> Retail Pharmacies
=> Online Pharmacies
Chapter - 8 Global Respiratory Tract Infection Market by Region 2019-2025
=> North America
Chapter - 9 Company Profiles and Competitive Landscape
=> Teva Pharmaceutical Industries Ltd.
=> AbbVie Inc.
=> GlaxoSmithKline plc
=> Pfizer Inc.
=> Novartis AG
=> Merck & Co., Inc.
=> F. Hoffmann-La Roche Ltd
=> Sanofi S.A.
Chapter - 10 Appendix
=> Primary Research Findings and Questionnaire
Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-respiratory-tract-infection-market
About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.